The European Medicines Agency is studying cases of myocardial infarction after vaccination with the “AstraZeneca” vaccine.

The European Medicines Agency is studying cases of myocarditis after vaccination with two doses of the “AstraZeneca” vaccine against Corona.

And the agency’s safety committee stated in an evaluation, the results of which were quoted by “Reuters”, that capillary leak syndrome should be added as a new side effect in the explanatory leaflet for the “AstraZeneca” vaccine.
The syndrome causes blood to leak from the smallest blood vessels into the muscles and body cavities, resulting in swelling and low blood pressure.

The committee first began studying these cases in April, and adds its recommendations to AstraZeneca’s concerns, including a possible link to rare blood clots.

Previously, the European Medicines Agency advised against injecting people with blood clots with the second dose of the “AstraZeneca” vaccine.

The committee is expanding its investigation to include cases of myocarditis after vaccination with “AstraZeneca” and other vaccines, including “Pfizer”, “Moderna” and “Johnson & Johnson”.